SCHEMBL6566020

SCHEMBL6566020

COC(=O)c1cc(NC(=O)Nc2ccc(F)c(F)c2)ccc1OC(c1ccccc1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.53
KMT2A Q03164 8/20 0.53
ALDH1A1 P00352 1/20 0.53
SMN1; SMN2 Q16637 5/20 0.49
LMNA P02545 3/20 0.49
CASR P41180 1/20 0.46
MAPT P10636 8/20 0.46
GAA P10253 2/20 0.46
CASP3 P42574 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
NPC1 O15118 5/20 0.45
RAB9A P51151 5/20 0.45
HTT P42858 3/20 0.45
NPSR1 Q6W5P4 2/20 0.45
KDM4E B2RXH2 3/20 0.44
KCNJ6 P48051 2/20 0.43
KCNJ5 P48544 2/20 0.43
KCNJ3 P48549 2/20 0.43
HTR2A P28223 1/20 0.43
HTR2C P28335 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6567960 0.91 NPC1 (0.49) MEN1KMT2AALDH1A1SMN1; SMN2LMNA
SCHEMBL6565821 0.91 MEN1 (0.58) MEN1KMT2AALDH1A1SMN1; SMN2LMNA
SCHEMBL6564577 0.91 KMT2A (0.49) MEN1KMT2AALDH1A1SMN1; SMN2LMNA
SCHEMBL6565992 0.90 MEN1 (0.53) MEN1KMT2AALDH1A1SMN1; SMN2LMNA
SCHEMBL6564786 0.90 KMT2A (0.61) MEN1KMT2AALDH1A1SMN1; SMN2LMNA
SCHEMBL6564700 0.89 NPC1 (0.59) MEN1KMT2AALDH1A1SMN1; SMN2LMNA
SCHEMBL6566986 0.89 AR (0.48) MEN1KMT2AALDH1A1SMN1; SMN2LMNA
SCHEMBL6564600 0.88 MEN1 (0.59) MEN1KMT2AALDH1A1SMN1; SMN2LMNA
SCHEMBL6566884 0.87 MEN1 (0.55) MEN1KMT2AALDH1A1SMN1; SMN2LMNA
SCHEMBL6567612 0.86 SMN1; SMN2 (0.56) MEN1KMT2AALDH1A1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 MEN1 4143/4885KMT2A 3137/4885ALDH1A1 907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.